• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病患者冠状动脉血流储备的预后影响

Prognostic Impact of Coronary Flow Reserve in Patients With CKD.

作者信息

Park Sugeon, Lee Seung Hun, Shin Doosup, Hong David, Joh Hyun Sung, Choi Ki Hong, Kim Hyun Kuk, Ha Sang Jin, Park Taek Kyu, Yang Jeong Hoon, Song Young Bin, Hahn Joo-Yong, Choi Seung-Hyuk, Gwon Hyeon-Cheol, Lee Joo Myung

机构信息

Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Department of Internal Medicine and Cardiovascular Center, Chonnam National University Hospital, Chonnam National University Medical School, Gwangju, Republic of Korea.

出版信息

Kidney Int Rep. 2022 Oct 8;8(1):64-74. doi: 10.1016/j.ekir.2022.10.003. eCollection 2023 Jan.

DOI:10.1016/j.ekir.2022.10.003
PMID:36644355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9832048/
Abstract

INTRODUCTION

Both coronary flow reserve (CFR) and chronic kidney disease (CKD) are known to be associated with adverse cardiac events. However, it is unclear how these prognostic factors are interrelated. This study evaluated the association between intracoronary physiologic indexes and CKD and their prognostic implications.

METHODS

A total of 351 patients without left ventricular systolic dysfunction (ejection fraction ≥ 40%) and not on dialysis whose revascularization was deferred based on fractional flow reserve (FFR) > 0.80 were analyzed. Depressed CFR was defined as CFR ≤ 2.0. The primary outcome was a composite of cardiac death or hospitalization for heart failure at 3 years.

RESULTS

Patients with CKD showed lower CFR than the non-CKD population (3.28 ± 1.77 vs. 2.60 ± 1.09,  < 0.001), mainly driven by increased resting coronary flow. There was no significant difference in hyperemic coronary flow, FFR, and index of microvascular resistance between the 2 groups. CFR was significantly associated with estimated glomerular filtration rate (eGFR) ( = 0.045), and the proportion of depressed CFR was significantly increased with higher CKD stages ( = 0.011). The risk of cardiac death or hospitalization for heart failure was the lowest in the non-CKD and preserved CFR group (11.9%) and the highest in the CKD and depressed CFR group (60.0%, overall log rank  < 0.001). Both CKD (adjusted hazard ratio [HR] 2.614, 95% confidence interval [CI] 1.505-4.539,  < 0.001) and depressed CFR (HR 3.237, 95% CI 2.015-5.199,  < 0.001) were independently associated with the risk of the primary outcome.

CONCLUSION

There was a significant association between severity of CKD and CFR. Both CKD and depressed CFR showed independent association with higher risk of cardiac death or hospitalization for heart failure.

摘要

引言

已知冠状动脉血流储备(CFR)和慢性肾脏病(CKD)均与不良心脏事件相关。然而,尚不清楚这些预后因素之间是如何相互关联的。本研究评估了冠状动脉内生理指标与CKD之间的关联及其预后意义。

方法

共分析了351例无左心室收缩功能障碍(射血分数≥40%)且未接受透析治疗、基于血流储备分数(FFR)>0.80而延迟血运重建的患者。CFR降低定义为CFR≤2.0。主要结局是3年内心脏性死亡或因心力衰竭住院的复合终点。

结果

CKD患者的CFR低于非CKD人群(3.28±1.77对2.60±1.09,<0.001),主要是由于静息冠状动脉血流增加所致。两组之间充血冠状动脉血流、FFR和微血管阻力指数无显著差异。CFR与估计肾小球滤过率(eGFR)显著相关(=0.045),且CFR降低的比例随CKD分期升高而显著增加(=0.011)。非CKD且CFR保留组心脏性死亡或因心力衰竭住院的风险最低(11.9%),而CKD且CFR降低组最高(60.0%,总体对数秩检验<0.001)。CKD(校正风险比[HR]2.614,95%置信区间[CI]1.505 - 4.539,<0.001)和CFR降低(HR 3.237,95%CI 2.015 - 5.199,<0.001)均与主要结局风险独立相关。

结论

CKD严重程度与CFR之间存在显著关联。CKD和CFR降低均与心脏性死亡或因心力衰竭住院的较高风险独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/5d8ad6cbba8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/d82207fdca6b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/5cd60b4943a4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/ce6e36c8197e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/ad66bf1c2d84/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/6f6c55e57b63/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/5d8ad6cbba8c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/d82207fdca6b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/5cd60b4943a4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/ce6e36c8197e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/ad66bf1c2d84/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/6f6c55e57b63/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6443/9832048/5d8ad6cbba8c/gr5.jpg

相似文献

1
Prognostic Impact of Coronary Flow Reserve in Patients With CKD.慢性肾脏病患者冠状动脉血流储备的预后影响
Kidney Int Rep. 2022 Oct 8;8(1):64-74. doi: 10.1016/j.ekir.2022.10.003. eCollection 2023 Jan.
2
Differential Prognostic Value of Revascularization for Coronary Stenosis With Intermediate FFR by Coronary Flow Reserve.冠状动脉血流储备指导下中等程度 FFR 狭窄的血运重建的预后价值差异。
JACC Cardiovasc Interv. 2022 May 23;15(10):1033-1043. doi: 10.1016/j.jcin.2022.01.297. Epub 2022 Apr 27.
3
Prognostic Implications of Resistive Reserve Ratio in Patients With Coronary Artery Disease.冠心病患者阻力储备比的预后意义。
J Am Heart Assoc. 2020 Apr 21;9(8):e015846. doi: 10.1161/JAHA.119.015846. Epub 2020 Apr 18.
4
Prognostic Impact of Coronary Flow Reserve in Patients With Reduced Left Ventricular Ejection Fraction.左心室射血分数降低患者中冠状动脉血流储备的预后影响。
J Am Heart Assoc. 2022 Aug 2;11(15):e025841. doi: 10.1161/JAHA.122.025841. Epub 2022 Jul 25.
5
Prognostic Impact of Coronary Microvascular Dysfunction According to Different Patterns by Invasive Physiologic Indexes in Symptomatic Patients With Intermediate Coronary Stenosis.症状性中度冠状动脉狭窄患者根据侵入性生理指标不同模式的冠状动脉微血管功能障碍的预后影响。
Circ Cardiovasc Interv. 2023 Mar;16(3):e012621. doi: 10.1161/CIRCINTERVENTIONS.122.012621. Epub 2023 Feb 27.
6
Physiologic Characteristics and Clinical Outcomes of Patients With Discordance Between FFR and iFR.FFR 与 iFR 不相符患者的生理学特征和临床结局。
JACC Cardiovasc Interv. 2019 Oct 28;12(20):2018-2031. doi: 10.1016/j.jcin.2019.06.044. Epub 2019 Sep 25.
7
Coronary flow abnormalities in chronic kidney disease: A systematic review and meta-analysis.慢性肾脏病中的冠状动脉血流异常:系统评价和荟萃分析。
Echocardiography. 2022 Nov;39(11):1382-1390. doi: 10.1111/echo.15445. Epub 2022 Oct 5.
8
Long-term Patient Prognostication by Coronary Flow Reserve and Index of Microcirculatory Resistance: International Registry of Comprehensive Physiologic Assessment.通过冠状动脉血流储备和微循环阻力指数进行长期患者预后评估:综合生理评估国际注册研究
Korean Circ J. 2020 Oct;50(10):890-903. doi: 10.4070/kcj.2020.0083. Epub 2020 May 27.
9
Prognostic Implication of Thermodilution Coronary Flow Reserve in Patients Undergoing Fractional Flow Reserve Measurement.热稀释法测量冠状动脉血流储备在接受血流储备分数测量患者中的预后意义。
JACC Cardiovasc Interv. 2018 Aug 13;11(15):1423-1433. doi: 10.1016/j.jcin.2018.05.005.
10
Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.2型糖尿病患者的微血管功能障碍:绝对冠状动脉血流和微血管阻力储备的有创评估
Front Cardiovasc Med. 2021 Oct 19;8:765071. doi: 10.3389/fcvm.2021.765071. eCollection 2021.

引用本文的文献

1
Endothelial dysfunction in chronic kidney disease: a clinical perspective.慢性肾脏病中的内皮功能障碍:临床视角
Am J Physiol Heart Circ Physiol. 2025 Jul 1;329(1):H135-H153. doi: 10.1152/ajpheart.00908.2024. Epub 2025 May 27.
2
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
3
Prognostic impact of coronary microvascular dysfunction assessed by AMR in acute coronary syndrome patients with chronic kidney disease.

本文引用的文献

1
Coronary Microcirculatory Dysfunction and Acute Cellular Rejection After Heart Transplantation.冠状动脉微血管功能障碍与心脏移植后急性细胞排斥反应
Circulation. 2021 Nov 2;144(18):1459-1472. doi: 10.1161/CIRCULATIONAHA.121.056158. Epub 2021 Sep 3.
2
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病:病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
3
An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group.
急性冠状动脉综合征合并慢性肾脏病患者中,通过自适应多分辨率分析评估的冠状动脉微血管功能障碍的预后影响。
Front Cardiovasc Med. 2025 Jan 7;11:1489403. doi: 10.3389/fcvm.2024.1489403. eCollection 2024.
4
Oxidative stress initiates hemodynamic change in CKD-induced heart disease.氧化应激引发慢性肾脏病所致心脏病中的血流动力学变化。
Basic Res Cardiol. 2024 Dec;119(6):957-971. doi: 10.1007/s00395-024-01085-7. Epub 2024 Oct 15.
5
Increased Cardiovascular Risk in Young Patients with CKD and the Role of Lipid-Lowering Therapy.慢性肾脏病(CKD)年轻患者心血管风险增加及降脂治疗的作用。
Curr Atheroscler Rep. 2024 Apr;26(4):103-109. doi: 10.1007/s11883-024-01191-w. Epub 2024 Jan 30.
6
Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD.慢性肾脏病患者冠状动脉微血管功能障碍的临床意义
Kidney Int Rep. 2022 Nov 19;8(1):10-13. doi: 10.1016/j.ekir.2022.11.010. eCollection 2023 Jan.
一份由欧洲心脏病学会冠状动脉病理生理学与微循环工作组合作完成,并经冠状动脉血管舒缩障碍国际研究组认可的关于非阻塞性冠状动脉缺血的欧洲经皮心血管介入学会专家共识文件。
Eur Heart J. 2020 Oct 1;41(37):3504-3520. doi: 10.1093/eurheartj/ehaa503.
4
Microvascular disease in chronic kidney disease: the base of the iceberg in cardiovascular comorbidity.慢性肾脏病中的微血管疾病:心血管合并症中的冰山一角。
Clin Sci (Lond). 2020 Jun 26;134(12):1333-1356. doi: 10.1042/CS20200279.
5
Prognostic Value of the Index of Microcirculatory Resistance Over Serum Biomarkers in Cardiac Amyloidosis.心脏淀粉样变性中微循环阻力指数相对于血清生物标志物的预后价值
J Am Coll Cardiol. 2020 Feb 11;75(5):560-561. doi: 10.1016/j.jacc.2019.11.045.
6
Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment.慢性肾脏损伤患者的冠状动脉微血管功能障碍、左心室重构和临床转归。
Circulation. 2020 Jan 7;141(1):21-33. doi: 10.1161/CIRCULATIONAHA.119.043916. Epub 2019 Nov 29.
7
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes.2019年欧洲心脏病学会慢性冠状动脉综合征诊断和管理指南
Eur Heart J. 2020 Jan 14;41(3):407-477. doi: 10.1093/eurheartj/ehz425.
8
Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.药物洗脱支架时代,根据慢性肾脏病的存在情况,血管造影完全与不完全冠状动脉血运重建的临床转归差异。
J Am Heart Assoc. 2018 Feb 15;7(4):e007962. doi: 10.1161/JAHA.117.007962.
9
Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.无论慢性肾脏病阶段如何,冠状动脉血流储备均可预测心血管死亡风险。
Kidney Int. 2018 Feb;93(2):501-509. doi: 10.1016/j.kint.2017.07.025. Epub 2017 Oct 13.
10
Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.第二代药物洗脱支架时代的慢性肾脏病:韩国多中心药物洗脱支架注册研究的汇总分析。
JACC Cardiovasc Interv. 2016 Oct 24;9(20):2097-2109. doi: 10.1016/j.jcin.2016.06.051. Epub 2016 Sep 28.